- ►endojournals.org GS Eisenbarth - Journal of Clinical Endocrinology & Metabolism, 2007 - Endocrine Soc Synthesis: There has been recent progress in defining the genetics, pathogenesis, and natural
history of the disease. In addition, there is a major effort to develop immunotherapies to prevent
the disorder and to cure the ... Cited by 30 - Related articles - All 3 versions
- ►diabetesjournals.org HC Yeh, NM Punjabi, NY Wang, JS Pankow, BB … - Diabetes Care, 2008 - Am Diabetes Assoc RESULTS—At baseline, adults with diabetes had significantly lower predicted FVC (96 vs. 103%, P <
0.001) and predicted FEV 1 (92 vs. 96%, P < 0.001) than those without diabetes. These differences
remained significant after ... Cited by 14 - Related articles - BL Direct - All 7 versions
VP Guntur, R Dhand - Respiratory care, 2007 - rtjournalonline.com Targeted glycemic control in patients with type 1 and type 2 diabetes is grossly inadequate, despite
data demonstrating reduced microvascular and macrovascular diabetic complications with inten- sive
treatment. A significant proportion ... Cited by 11 - Related articles - View as HTML - BL Direct - All 5 versions
GT McMahon, RA Arky - N Engl J Med, 2007 - scielo.oces.mctes.pt Resumo A propósito de um doente com diabetes mellitus (DM) tipo 2, com controlo glicémico
insuficiente com agen- tes orais, é feita uma recomendação terapêutica baseada na discussão
clínica e no mecanismo de ... Cited by 27 - Related articles - View as HTML - BL Direct - All 14 versions
M Hegewald, RO Crapo, RL Jensen - Diabetes Technology & …, 2007 - liebertonline.com The need for frequent insulin injections to achieve optimal glycemic control remains a major barrier
to initiating and maintaining insulin therapy in diabetes. The inhaled route of insulin ad-
ministration offers many potential ... Cited by 9 - Related articles - BL Direct - All 3 versions
AK Steck, GJ Klingensmith, R Fiallo-Scharer - Pediatric Diabetes, 2007 - interscience.wiley.com Abstract: Since the findings of the Diabetes Control and Complications Trial became public in 1993,
intensive insulin therapy has been recommended for all children. However, successful implementation
remains a challenge because of ... Cited by 7 - Related articles - BL Direct - All 3 versions
- ►utsouthwestern.edu [PDF] CCW Hsia, P Raskin - Diabetes Technology & Therapeutics, 2007 - liebertonline.com Diabetic microangiopathy targets the lung as it does other organs. Even though respiratory
dysfunction in most patients with diabetes is subclinical and rarely the presenting complaint, there
are several reasons why pulmonary ... Cited by 7 - Related articles - BL Direct - All 9 versions
G Dailey - Clinical therapeutics, 2007 - Elsevier Results: Eight clinical studies to date have reported that IDPI consistently improved glycemic
control, whether used in combination with longer-acting SC insulin regimens in patients with type 1
or type 2 DM or to supplement or ... Cited by 6 - Related articles - All 3 versions
CJ Bailey, AH Barnett - British Medical Journal, 2007 - bmj.com On 18 October Pfizer announced that it would withdraw the first inhaled insulin, Exubera, from the
market, as sales were too low. In January 2006 Pfizer bought the worldwide rights to Exubera from
Sanofi-Aventis for $1.3bn (£0.6bn; ... Cited by 6 - Related articles - BL Direct - All 2 versions
C Mathieu, EAM Gale - Diabetologia, 2008 - Springer Yesterday it was going to sweep the world; today it is gone. Exubera is no more: there was no money
in it. As for the patients who volunteered to test the new therapy, and those to whom it has offered
a new lease of life: tough luck. ... Cited by 5 - Related articles - BL Direct - All 3 versions
